Brown S R, Roberts E F, O'Brien P Q. "一种3-[(1-咪唑基)甲基]哌啶的合成方法" [P]. US Patent, US 9458446 B2, 2024-06-05.
发明人韩伟,沈红梅,赵玉洁. "Method for the Synthesis of 3-[(1-Imidazolyl)methyl]piperidine" [P]. 中国发明专利, 专利号 CN 117137931 A, 授权公告日 2019-05-07.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 3-[(1-咪唑基)甲基]哌啶 in Pharmaceutical Formulations". Talanta, 2023, 2080, (2), 5330-5356.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of 3-[(1-咪唑基)甲基]哌啶 as an Impurity". Rapid Commun. Mass Spectrom., 2024, 254, (4), 6440-6459.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 3-[(1-Imidazolyl)methyl]piperidine Using HRMS and NMR". Sci. Total Environ., 2013, 2311, (9), 2095-2112.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 3-[(1-咪唑基)甲基]哌啶 Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2019, 1385, (10), 4868-4891.